Study compares arm measures to BMI for assessing nutritional status of leukemia survivors

Arm anthropometry is a simple method to determine if a person is overweight or obese, and because it can distinguish between fat and muscle mass, unlike body mass index (BMI), it is a valuable method for assessing muscle loss in long-term survivors of childhood cancer. A new study that compares two arm anthropometry measures to BMI to determine the nutritional status of leukemia survivors is published in Journal of Adolescent and Young Adult Oncology (JAYAO), a multidisciplinary peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the JAYAO website.

In the article "Anthropometry in Long-Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence," the researchers discuss the value of this easy approach to evaluating for obesity and loss of muscle mass in this at-risk population, especially in lower socioeconomic populations where access to more costly tools for measuring body composition may not be available.

Laura Collins, Amy Cranston, Stefanie Savoie, Trishana Nayiager, and Ronald Barr, MB ChB, MD, McMaster Children's Hospital and McMaster University, and Lesley Beaumont, Hamilton Health Sciences (Hamilton, Ontario, Canada) compared BMI to two different arm measures: triceps skin fold thickness, which indicates a person's fat mass; and mid-upper arm circumference, which correlates to lean body mass.​

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients